These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16975)

  • 21. Proceedings: Purification of ristocetin Willebrand factor (RWF).
    Olson JD; Fass DN; Brockway WJ; Bowie EJ; Mann KG
    Thromb Diath Haemorrh; 1975 Nov; 34(2):606. PubMed ID: 1081753
    [No Abstract]   [Full Text] [Related]  

  • 22. Willebrand factor: immunological and biological study.
    Meyer D; Dreyfus MD; Larrieu MJ
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:66-71. PubMed ID: 4202741
    [No Abstract]   [Full Text] [Related]  

  • 23. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

  • 24. von Willebrand factor: characterization of interaction among von Willebrand factor, ristocetin and platelet.
    Hashimoto S; Suzuki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):851-63. PubMed ID: 317771
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M; Yasui M; Nishino M; Mikami S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract]   [Full Text] [Related]  

  • 26. An improvemed assay for von Willebrand factor.
    Head DR; Bowman RP; Marmer DJ; Brossoit AD
    Am J Clin Pathol; 1979 Dec; 72(6):991-5. PubMed ID: 117698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis of Von Willebrand's syndrome (author's transl)].
    Hariga-Muller C; Capel P; De Maertelaere-Laurent E; Masramon AM; Fondu P
    Rev Med Brux; 1981 Mar; 2(3):245-50. PubMed ID: 6785854
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence that the platelet retention factor is separate from the factor VIII-related antigen and factor VIII.
    Rubin H; Alter AA; Walker MR; Stefanyshyn M; Scott L; Miotti AB
    J Lab Clin Med; 1976 Jul; 88(1):14-21. PubMed ID: 180215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet function and immunologic parameters in von Willebrand's disease following cryoprecipitate and factor VIII concentrate infusion.
    Chediak JR; Telfer MC; Green D
    Am J Med; 1977 Mar; 62(3):369-76. PubMed ID: 300224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological diagnosis of von Willebrand's disease (author's transl)].
    Castillo R; Maragall S; Liendo F; Ordinas A
    Sangre (Barc); 1978; 23(5B):728-45. PubMed ID: 310168
    [No Abstract]   [Full Text] [Related]  

  • 32. [Von Willebrand's disease (author's transl)].
    Fukui H
    Rinsho Ketsueki; 1977 May; 18(5):575-86. PubMed ID: 333144
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein.
    Fukui H; Yoshioka A; Mikami S; Takase T; Fujimura Y; Takahashi Y; Nishino M; Iwagaki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):839-50. PubMed ID: 121660
    [No Abstract]   [Full Text] [Related]  

  • 34. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemophilia and von Willebrand's disease. Some biological determinants. H. P. Smith memorial lecture.
    Brinkhous KM
    Am J Clin Pathol; 1975 May; 63(5):609-17. PubMed ID: 1093384
    [No Abstract]   [Full Text] [Related]  

  • 36. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results].
    Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M
    Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Structure and function of clotting factor VIII: the results of fundamental research].
    Beck EA; Furlan M
    Ther Umsch; 1979 Apr; 36(4):294-300. PubMed ID: 377554
    [No Abstract]   [Full Text] [Related]  

  • 38. An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE).
    Kasatkar P; Ghosh K; Shetty S
    Ann Hematol; 2014 Jan; 93(1):173-5. PubMed ID: 23625134
    [No Abstract]   [Full Text] [Related]  

  • 39. Heterogeneity in biological activity of human factor VIII antibodies.
    Koutts J; Meyer D; Rickard K; Stott L; Firkin BG
    Br J Haematol; 1975 Jan; 29(1):99-107. PubMed ID: 1081403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
    Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
    Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.